Anaphylaxis
NS IV
H1 blockers
H2 blockers
β2 agonists → bronchodilation
Steroids
Asthma
Asthma control
Risk stratification
mild | moderate | severe | |
PEF (% predicted or % personal best) | 80-100% | 50-80% | < 50% or response lasts < 2 hrs |
Risk factors for death
Emergency Tx
Aerosolized β2 agonist:
Salbutamol (Ventolin) by nebulizer e.g. q20min, then q1h, then q4h as pt improves (may be given continuously if needed).
≤ 10 kg: 1.25-2.5 mg in 3 mL normal saline
11-20 kg: 2.5 mg in 3 mL NS
> 20 kg: 5.0 mg in 3 mL normal saline
Prenisone 1mg/kg/day PO
Epinephrine SC
β2 → bronchodilation
α1 → ↑ peripheral vascular resistance
Ketamine
Acts on cortex and limbic system → bronchodilation
MgSO4
Smooth muscle relaxation → bronchodilation
Stage | PFTs | Rx |
0 - At risk | Normal - chronic intermittent symptoms | Eliminate exposures (e.g. tobacco) |
I - Mild | FEV1/FVC <70%, FEV1 >80% | Short-acting beta-2 agonist 2 puffs QID prn |
II - Moderate | FEV1 50-80% | Add inhaled anticholinergic (e.g. ipratropium 2 inh. QID prn [max. 12 per 24 hrs])
(OR substitute w. Combivent 2 inh QID) Add long-acting beta-2 agonist OR Advair Add low-flow oxygen at night and with exertion |
III - Severe | FEV1 30-50% | Add leukotriene receptor antagonist
? Add theophylline |
IV - Very severe | FEV1 <30% | Add buspirone (anxiolysis)
Add MS Contin 10 mg q12h (for dyspnea) |
Home Oxygen
Indications:
Stable clinical status
If no end-organ dysfunction: PaO2 < 55 mmHg or O2 < 88%
If end-organ dysfunction: PaO2 < 60 mmHg or O2 < 90%
Acute exacerbation of COPD
Short-acting beta-2 agonist up to 6-8 puffs q1-2h
Ipratropium up to 6 to 8 puffs q3-4h
Prednisone 30-40 mg/day PO x 10 days, then tapered over 2 weeks
OR
Solu-Medrol 1-2 mg/kg q6-12 hours IV x 3 days, then Prednisone 60 mg qd x 7 days, then tapered over 2 weeks
ABx if ↑ dyspnea + ↑ sputum + purulent sputum
Orgs: H. influenzae, S. pneumoniae, M. catarrhalis, C. pneumoniae, M. pneumoniae
First-Line:
Bactrim DS one tablet PO bid
Doxycycline 100 mg PO bid
Amoxicillin 500 mg PO tid
Alternatives:
Augmentin 875 mg PO BID
Clarithromycin 500 mg PO BID
Azithromycin 500 mg day 1, then 250 mg PO x4 days
Levofloxacin x 7 days
CAP in adults
No co-morbid factors
Pulmonary embolism
Wells criteria for PE (Wells PS, et al. Ann Intern Med 2001;135:98)
Clinical S&S's of DVT
(leg swelling and pain with palpation) | 3.0 |
No alternative diagnosis is more likely than PE | 3.0 |
HR > 100 | 1.5 |
Immobilization > 3 days
or surgery in previous 4 weeks | 1.5 |
Previous DVT/PE | 1.5 |
Hemoptysis | 1.0 |
Malignancy (treated within previous 6 mos or palliative) | 1.0 |
Probability of PE:
High | > 6 |
Moderate | 2 - 6 |
Low | < 2 |
Wells criteria for DVT:
(Possible score -2 to 9)
Active cancer (treatment within
last 6 months or palliative) | 1 |
Calf swelling >3 cm compared to other calf
(measured 10 cm below tibial tuberosity) | 1 |
Collateral superficial veins (non-varicose) | 1 |
Pitting edema (confined to symptomatic leg) | 1 |
Swelling of entire leg | 1 |
Localized pain along distribution
of deep venous system | 1 |
Paralysis, paresis, or recent cast
immobilization of lower extremities | 1 |
Recently bedridden > 3 days, or major
surgery requiring regional or general anesthetic in past 12 weeks | 1 |
Previously documented DVT | 1 |
Alternative diagnosis at least as likely | -2 |
Interpretation:
Score ≥ 2: DVT likely. Consider US leg veins.
Score < 2: DVT unlikely. Consider d-dimer test to further rule out DVT.
Mgt: